Schwabe Group
Stefan Bolz has a diverse work experience starting in 2007. Stefan worked as a Senior Consultant at Campana & Schott from 2010 to 2014 and was also involved in project management consulting during that time. Stefan then joined Dr. Willmar Schwabe Business Services in 2015, where they worked in the Project Management Office and later in Organisationsentwicklung until 2023. In 2019, they joined Schwabe Group as the Head of Project Management Consulting and currently holds the position of Head of Processes, Transformation Office, PMP. Prior to these roles, Stefan Bolz worked in quality management at E.G.O. Elektrogerätebau and Volkswagen Group China.
Stefan Bolz has a Diplom in Wirtschaftsingenieur from the Karlsruhe Institute of Technology (KIT). Stefan also has additional certifications in Turnaround- und Transformations-Management and Strategische Planung – Grundlagen obtained from LinkedIn in 2024 and 2023, respectively. In 2017, they obtained the Project Management Professional (PMP) certification from PMI and in 2014, they obtained the PRINCE2 Foundation certification from APMG International.
This person is not in any teams
Schwabe Group
The Schwabe Group comprises several different affiliated companies in the pharmaceutical and health industry. All of the companies within the Group focus on plants as the basis for developing pharmaceuticals and health products. The original form of the Group’s parent company, which is now Dr. Willmar Schwabe GmbH & Co. KG, is one of the oldest pharmaceutical manufacturers in Europe and has a company history dating back over 150 years. We do so by researching and developing plant-based medicines and health-care products. Our goal is to create value through innovation. We believe that innovative phytomedicines will become increasingly important over the next few decades. By influencing several target systems in the body at the same time, they may be more appropriate for patients suffering from complex or age-related diseases than is the “silver bullet” approach of synthetic medicines. In the future, phytomedicines will help people, worldwide, to lead a sustainable, productive and healthy life. We are actively shaping the company’s international future in a changing and challenging global market. Our goal is to maintain our market-leadership in phytomedicines by introducing our products into new markets, expanding our network of affiliates and distribution partners, and providing more extensive access to our health-care solutions. The commitment, experience and creativity of our employees are the source of our success. At Schwabe Pharmaceuticals we share a common vision: “From Nature. For Health”. We would like to invite you to learn more about this vision and our company on this website.